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Purpose: To identify the molecular defect underlying an autosomal dominant congenital nuclear cataract in a Chinese
family.
Methods: Twenty-two members of a three-generation pedigree were recruited, clinical examinations were performed,
and genomic DNA was extracted from peripheral blood leukocytes. All members were genotyped with polymorphic
microsatellite markers adjacent to each of the known cataract-related genes. Linkage analysis was performed after
genotyping. Candidate genes were screened for mutation using direct sequencing. Individuals were screened for presence
of a mutation by restriction fragment length polymorphism (RFLP) analysis.
Results: Linkage analysis identified a maximum LOD score of 3.31 (recombination fraction [θ]=0.0) with marker
D22S1167 on chromosome 22, which flanks the β-crystallin gene cluster (CRYBB3, CRYBB2, CRYBB1, and CRYBA4).
Sequencing the coding regions and the flanking intronic sequences of these four candidate genes identified a novel,
heterozygous C→T transition in exon 6 of CRYBB1 in the affected individuals of the family. This single nucleotide change
introduced a novel BfaI site and was predicted to result in a nonsense mutation at codon 223 that changed a phylogenetically
conserved amino acid to a stop codon (p.Q223X). RFLP analysis confirmed that this mutation co-segregated with the
disease phenotype in all available family members and was not found in 100 normal unrelated individuals from the same
ethnic background.
Conclusions: This study has identified a novel nonsense mutation in CRYBB1 (p.Q223X) associated with autosomal
dominant congenital nuclear cataract.
Cataract is the most common treatable cause of visual
disability in both childhood (congenital cataract) and in adults
(age-related  cataract).  The  prevalence  estimates  for
congenital  cataract  vary  over  10-fold  from  0.6/10,000  to
6.0/10,000, depending on the method of ascertainment. The
condition can occur in isolation or as part of a more complex
syndrome [1]. Over the past few years, remarkable progress
has been made toward our understanding of the process of
cataractogenesis. Currently, there are more than 40 genetic
loci to which isolated or primary cataracts have been mapped
and more than 30 genes have been characterized, although this
number is constantly increasing [2].
Crystallins are known to constitute about 90% of the
water-soluble  proteins  of  the  lens  and  contribute  to
transparency  and  refractive  properties  due  to  a  uniform
concentration gradient [3,4]. They fall into two classes, the
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α-crystallin  family  and  the  β/γ-crystallin  superfamily.
Because of high levels of expression in the lens, crystallins
represent compelling candidate genes for inherited cataracts.
Indeed, defects in crystallin genes have been shown to be
associated with human cataract formation [4]. To date, many
mutations in 12 human crystallin genes have been associated
with inherited autosomal dominant (AD) and/or autosomal
recessive (AR) cataract. These genes are linked to 1q for
CRYZ [5], 2q for CRYGC/D [6,7], 3q for CRYGS [8], 11q for
CRYAB  [9],  17q  for  CRYBA1/3  [10-16],  21q  for  CRYAA
[17],  and  22q  for  CRYBB1  [18-21],  CRYBB2  [22-27],
CRYBB3 [28], and CRYBA4 [29].
CRYBB1  is  a  major  subunit  of  the  β-crystallins  and
comprises 9% of the total soluble crystallin in the human lens
[30].  The  amino-  and  carboxyl-terminal  extensions  of  β-
crystallins  are  presumed  to  be  of  importance  in  protein
aggregation and orientation, and loss of the terminal arms can
either increase or decrease dimerization of the β-crystallins,
which  causes  cataract  formation  [31].  Mackay  et  al.  [18]
identified a mutation in CRYBB1, G220X, to be associated
with autosomal dominant pulverulent cataract and suggested
that  the  mutation  disrupts  the  fourth  Greek  key  motif,
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727probably causing instability of CRYBB1. Three additional
mutations  in  CRYBB1  associated  with  AD  and/or  AR
congenital cataract have previously been reported [19-21].
Herein, we report the identification of a novel nonsense
mutation (c.C737T) in CRYBB1 that introduces a translation
stop codon at Gln (p.Q223X). This mutation is responsible for
autosomal dominant congenital nuclear cataract affecting a
three-generation Chinese family. To our knowledge, this is
the first reported case of nuclear cataracts associated with the
CRYBB1 mutation Gln223X.
METHODS
Clinical evaluations and DNA specimens: A three-generation
family with non-syndromic congenital nuclear cataracts was
recruited at the First Affiliated Hospital of Fujian Medical
University, Fuzhou, China. Twenty-two individuals took part
in  this  study  including  10  affected  and  12  unaffected
individuals  (Figure  1).  Clinical  and  ophthalmologic
examinations were performed on the affected individuals as
well as on the unaffected family members. The diagnosis of
cataract  was  confirmed  in  each  affected  patient  by
ophthalmologic examination. Phenotype was documented by
slit  lamp  photography  (Figure  2).  Informed  consent  was
obtained  from  each  participant,  consistent  with  the
Declaration of Helsinki. Genomic DNA was extracted from
peripheral blood leukocytes using the Wizard Genomic DNA
Purification  Kit  (Promega,  Beijing,  China)  according  to
manufacturer’s instructions.
Genotyping: Exclusion analysis was performed in affected
individuals  from  different  generations  with  polymorphic
microsatellite markers flanking 32 candidate genes [20] to
determine whether all affected individuals share the same
allele. The genotyping was performed using microsatellite
markers  as  previously  described  [21,32].  Pedigree  and
haplotype data were managed using Cyrillic (version 2.1)
software.
Figure 1. Cataract pedigree and haplotype analysis. Pedigree and
haplotype analysis of the cataract family shows the segregation of
three microsatellite markers on chromosome 22q11.2–12.1, which is
listed in descending order from the centromere. Squares and circles
symbolize males and females, respectively. The clear and shaded
symbols denote unaffected and affected individuals, respectively.
The proband is marked with an arrow.
Linkage analysis: Two-point linkage LOD scores (Z) were
calculated as previously described [21,32]. The marker order
and  distances  between  the  markers  were  taken  from  the
NCBI and GDB databases.
Mutational analysis: Genomic DNA samples from affected
and unaffected members of the family and from 100 ethnically
matched control individuals were screened for mutations in
CRYBB3,  CRYBB2,  CRYBB1,  and  CRYBA4  with  a
combination  of  direct  cycle  sequencing  and  restriction
fragment  length  polymorphism  (RFLP)  analysis.  Briefly,
individual exons of these four candidate genes were amplified
by polymerase chain reaction (PCR), and PCR products were
sequenced on an ABI 3730XL Automated Sequencer (PE
Biosystems, Foster City, CA), using gene specific primers, as
previously described [21].
For RFLP analysis, specific primers were designed to
amplify part of CRYBB1 exon 6, forward: 5′-TAG AGC CTG
GTG ACT TCC G-3′, and reverse: 5′-GGT AGC AGA GTG
AGG TGT GG-3′. The reaction was performed with PCR
master  mix  (Premix  TaqTM,  Ex  Taq  Version;  TAKARA
Biotechnology Co., Ltd, Dalian, China), and conditions were
as follows: 94 °C for 1 min; 35 cycles at 94 °C for 30 s, 58 °C
for 30 s, and 72 °C for 30 s; and 1 cycle of 72 °C for 7 min.
Restriction  enzyme  digestion  was  performed  using  BfaI
(TaKaRa) according to manufacturer’s instructions.
Amino acid sequences for CRYBB1 were retrieved from
NCBI.  Multiple  sequence  alignments  of  CRYBB1  from
various species were performed using DNAMAN software
(version 5.0, Lynnon Corp., Quebec, Canada).
RESULTS
Clinical  data:  This  three-generation  family  included  10
affected individuals with congenital nuclear cataract and 15
unaffected individuals (Figure 1). All affected individuals
presented disc-like opacities in the central nucleus region of
both lenses. However, younger affected individuals (III:4, III:
6, III:8, and III:9; aged between 5 and 12) presented thin, gray
opacities located mainly in the fetal nuclei and less in the
embryonic nuclei. The older affected individuals (I:2, II:4, II:
Figure 2. Photograph of affected individuals. All of the affected
family members exhibited a nuclear cataract phenotype. The lens
opacity increased with age in the affected individuals of this family
(A: III:9, aged 5; B: II:4, aged 41).
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7286, II:8, II:10, and II:12; aged between 31 and 65) showed
dense, white opacities distributed throughout the embryonic
and fetal nuclei. Overall, lens opacity increased with age in
the  affected  individuals  of  this  family  (Figure  2A,B).
Ophthalmic records confirmed that the opacities were present
from birth and that there was no family history of other ocular
or systemic abnormalities.
Linkage and haplotype analysis: All known cataract-related
candidate  genes  were  excluded  by  allele-sharing  analysis
except for a cluster of β-crystallin genes on chromosome 22
(CRYBB3, CRYBB2, CRYBB1, and CRYBA4; data not shown).
Significant and suggestive linkage was found with markers
D22S1167 (LOD score [Z]=3.31 at recombination fraction
[θ]=0.0),  D22S315  (LOD  score  [Z]=0.903,  recombination
fraction  [θ]=0.0),  and  D22S1174  (LOD  score  [Z]=0.602,
recombination  fraction  [θ]=0.0;  Table  1).  These  markers
closely flank the CRYBB3, CRYBB2, CRYBB1, and CRYBA4
gene cluster. Haplotype analysis indicated that the disease
gene was close to these three markers (Figure 1), implying
that  one  or  more  of  the  geness,  CRYBB3,  CRYBB2,
CRYBB1, and CRYBA4, might be responsible for the disease.
Mutation analysis: Direct sequencing of the coding regions
and of the flanking intronic sequences of CRYBB3, CRYBB2,
CRYBB1, and CRYBA4 in two affected individuals revealed
no  nucleotide  changes  except  a  heterozygous  c.C737T
transition in exon 6 of CRYBB1 (nucleotide change based on
sequence NM_001887; gi:21536279; Figure 3B). This single
nucleotide change introduced a novel BfaI site, C/TAG, and
was predicted to result in a nonsense or chain-termination
mutation  at  codon  223.  This  changed  a  phylogenetically
conserved  glutamine  to  a  stop  codon  (p.Q223X).  The
remainder  of  the  CRYBB1  coding  sequence  showed  no
change. BfaI digestion analysis confirmed that this sequence
alteration, Q223X, co-segregated with affected individuals
but  not  with  unaffected  family  members  (Figure  3C).  In
addition, this single-nucleotide change was not detected in
100  normal  unrelated  individuals  from  the  same  ethnic
background. This suggested that it was the causative mutation
rather  than  a  rare  polymorphism  in  strong  linkage
disequilibrium with the disease in this pedigree. The multiple
sequence alignments generated using DNAMAN software
showed that the Gln at position 223 of human CRYBB1 is
highly conserved in Mus musculus, Rattus norvegicus, Bos
taurus,  Cavia  porcellus,  Gallus  gallus,  Danio  rerio,  and
Xenopus tropicalis (Figure 3D).
Figure  3.  Mutation  analysis  of  CRYBB1.  A:  The  sequence
chromatogram of a wild type allele shows glutamine (CAG) at codon
223. B: The sequence chromatogram of a mutant allele shows a
heterozygous C→T transition that changed glutamine 223 to a stop
codon (TAG). C: RFLP analysis illustrates that the mutation, Q223X,
introduces a new BfaI site. This mutation-specific BfaI digestion
pattern  co-segregated  with  the  disease  phenotype.  Squares  and
circles symbolize males and females, respectively. The clear and
shaded  symbols  denote  unaffected  and  affected  individuals,
respectively. D: Multiple sequence alignment of the fourth Greek key
motif of CRYBB1 is shown from Homo sapiens (codons 191–233),
Mus  musculus,  Rattus  norvegicus,  Bos  Taurus,  Cavia  porcellus,
Gallus gallus, Danio rerio, and Xenopus tropicalis. The Gln223
residue  is  highly  conserved.  “X”  indicates  premature  chain-
termination mutations in human CRYBB1 (Q223X).
TABLE 1. TWO-POINT LOD SCORES FOR LINKAGE BETWEEN CATARACT LOCUS AND CHROMOSOME 22 MARKERS.
Marker
LOD scores at recombination for values of θ
0 0.01 0.05 0.1 0.2 0.3 0.4 Zmax
D22S1174 0.6 0.59 0.56 0.51 0.41 0.29 0.16 0.6
D22S315 0.9 0.88 0.77 0.64 0.38 0.16 0.03 0.9
D22S1167 3.31 3.26 3.04 2.76 2.15 1.46 0.69 3.31
Two-point LOD scores for linkage in microsatellite markers across the β-crystallin gene cluster in the chromosomal regions
22q11.2-q12.1 is displayed. Significant linkage was found with marker D22S1167 (Zmax=3.31, at θ=0.0).
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The  β-crystallins  belong  to  the  β/γ-crystallin  superfamily,
which contain central globular cores, consisting of Greek key
motifs, a term used because the motif contains a quadruple
repeat of a β-sheet that resembles the characteristic pattern
found on classical Greek pottery [33]. Many studies have
demonstrated that mutations in β-crystallin genes, including
CRYBB1  [18-21],  CRYBB2  [22-27],  CRYBB3  [28],
CRYBA1/3 [10-16], and CRYBA4 [29], are associated with
inherited AD and/or AR cataract.
In  the  present  study,  we  have  demonstrated  that  an
autosomal dominant congenital nuclear cataract condition is
caused by a mutation in CRYBB1. This mutation resulted in a
nonsense or chain-termination mutation at codon 223 in the
Greek key IV motif. This changed a glutamine to a stop codon
(p.Q223X) and was predicted to truncate wild type CRYBB1
by 30 amino acids. Mackay et al. [7] have identified a similar
chain-termination  mutation,  G220X,  in  CRYBB1  that  is
associated  with  autosomal  dominant  pulverulent  cataract.
This mutation also occurs in the Greek key IV motif and was
predicted to truncate wild type CRYBB1 by 33 amino acids.
Furthermore, the expression of recombinant human CRYBB1
in bacteria showed that the truncated G220X mutant was
significantly less soluble than the wild type, suggesting that
this mutation disrupted the fourth Greek key motif, which
resulted in the instability of the molecule [18].
In addition, another similar chain-termination mutation
(Q155X) in CRYBB2 [22,23] was predicted to remove the last
51 amino acids of CRYBB2, deleting ∼90% of the fourth
Greek-key motif (codons 155–192) and the entire COOH-
terminal region (codons 193–205). The Q155X mutant in
CRYBB2 shows decreased ordered structure and stability, but
the partially unfolded protein retains some dimer structure,
suggesting  this  truncation  mutation  might  contribute  to
cataract  formation  [34].  Cohen  et  al.  [20]  describe  a
recessively inherited congenital cataract condition caused by
a homozygous delG168 mutation in exon 2 of CRYBB1 that
generates a frameshift, leading to a missense protein sequence
at amino acid 57 and truncation at amino acid 107 of the 252-
amino acid CRYBB1. From the above evidence, we suggest
that the Q223X mutant, lacking more than 25% of the fourth
Greek-key  motif  and  the  entire  COOH-terminal  region
(Figure 3D), has decreased stability or has altered higher order
aggregation, which results in cataractogenesis. Interestingly,
Willoughby et al. [19] report another dominant mutation in
CRYBB1  associated  with  autosomal  dominant  congenital
cataract and micro-cornea. This mutation generated an X253R
change, leading to the elongation of the COOH-terminus. This
study  also  implies  that  CRYBB1  plays  a  role  not  only  in
cataractogenesis but also in ocular development [19].
All  reported  mutations  of  CRYBB1  associated  with
autosomal  dominant  congenital  cataract  occur  in  exon  6,
which encodes the Greek key IV and the COOH-terminal arm
[18,19,21]. Although the deletion of COOH-terminal residues
from rat CRYBB2 [35], chicken CRYBB1 [36], and human
CRYBB1 [37] did not significantly impair solubility or the
ability to form dimers in vitro, all known mutations (such as
G220X  CRYBB1  [18],  Q223X  CRYBB1  (in  this  study),
Q155X  CRYBB2  [22,23]  and  del185QSVR188  CRYBB2
[38]) suggest that disruption of the fourth Greek key motif in
CRYBB1 or in CRYBB2 results in β-crystallin instability and/
or cataract disease.
In  conclusion,  we  report  a  novel  nonsense  mutation
(Q223X) in CRYBB1 in a family with autosomal dominant
congenital nuclear cataract. It occurs within the same gene,
CRYBB1, but the clinical phenotypes were dissimilar with
those reported by Mackay et al. [18], Willoughby et al. [19],
and Cohen et al. [20], and were similar with our previously
described  phenotype  [21].  These  results  provide  strong
evidence that CRYBB1 is a pathogenic gene for congenital
cataract and the Greek key motif IV is an important structural
domain in CRYBB1 for cataract formation.
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